Alzheimer degeneration in Down syndrome. Electrophysiologic alterations and histopathologic findings
- PMID: 126052
- DOI: 10.1001/archneur.1975.00490510074006
Alzheimer degeneration in Down syndrome. Electrophysiologic alterations and histopathologic findings
Abstract
Progressive electroencephalographic disorganization and decreased voltage amplitude in the late components of the averaged visual evoked potentials were recorded in the last two years of life of a patient with Down disease and Alzheimer degeneration. Taken together with quantitative histopathologic findings, the electrophysiologic alterations are interpreted in terms of recent evidence from an experimental animal model of dementia. Neurons with neurofibrillary degeneration become electrically inactive and contribute to the loss of voltage generators associated with neuron death in Alzheimer disease. Loss of voltage generators may result in disfacillitation and disinhibition of surviving neurons, thus causing the loss of normal rhythms.
Similar articles
-
Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia.Ann Neurol. 1980 May;7(5):462-5. doi: 10.1002/ana.410070512. Ann Neurol. 1980. PMID: 6446875
-
Alzheimer's disease in Down's syndrome: visual retention deficits.Cortex. 1974 Dec;10(4):366-77. doi: 10.1016/s0010-9452(74)80029-8. Cortex. 1974. PMID: 4281378 No abstract available.
-
Clinicopathologic features of Alzheimer disease in Down syndrome.Prog Clin Biol Res. 1992;379:15-34. Prog Clin Biol Res. 1992. PMID: 1409742 Review. No abstract available.
-
Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late onset epilepsy.Epilepsy Res. 2007 Dec;77(2-3):165-8. doi: 10.1016/j.eplepsyres.2007.09.002. Epub 2007 Oct 24. Epilepsy Res. 2007. PMID: 17961983
-
Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.Ann N Y Acad Sci. 1986;477:247-60. doi: 10.1111/j.1749-6632.1986.tb40344.x. Ann N Y Acad Sci. 1986. PMID: 2949682 Review. No abstract available.
Cited by
-
The limbic system in Alzheimer's disease. A neuropathologic investigation.Am J Pathol. 1976 Oct;85(1):1-20. Am J Pathol. 1976. PMID: 135514 Free PMC article.
-
Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection.Mol Aspects Med. 2018 Dec;64:18-33. doi: 10.1016/j.mam.2018.09.003. Epub 2018 Oct 1. Mol Aspects Med. 2018. PMID: 30244005 Free PMC article. Review.
-
Down's syndrome and the links with Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1995 Aug;59(2):111-4. doi: 10.1136/jnnp.59.2.111. J Neurol Neurosurg Psychiatry. 1995. PMID: 7629521 Free PMC article. No abstract available.
-
Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms.Brain Cogn. 2016 Apr;104:48-57. doi: 10.1016/j.bandc.2016.02.007. Epub 2016 Feb 27. Brain Cogn. 2016. PMID: 26930369 Free PMC article. Review.
-
Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.Acta Neuropathol. 1980;50(1):19-24. doi: 10.1007/BF00688530. Acta Neuropathol. 1980. PMID: 7376825
MeSH terms
LinkOut - more resources
Full Text Sources